Evidence map›Paper›PMID 36600260›Full record

ArticleArchives of public health = Archives belges de sante publique2023

Response to back-to-back outbreaks of circulating vaccine-derived poliovirus type 2 in two nomadic pastoralist settlements in Oti Region, Ghana-2019.

Donne Kofi Ameme, Yaw Ofori Yeboah, John Kofi Odoom, Senanu Kwesi Djokoto, Ernest Akyereko, Abdulaziz Mamudu, Mukaila Diwura, William Opare, Patrick Avevor, Stanley Diamenu and 3 more

Open access · goldAbstract read
In one paragraph

Article in Archives of public health = Archives belges de sante publique, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
3.5field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 16 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 3 institutions in 1 country.

Donne Kofi AmemeGhana Field Epidemiology and Laboratory Training Programme, University of Ghana School of Public Health, Accra, Legon, Ghana. amemedonne@yahoo.com.ORCID http://orcid.org/0000-0002-1017-7155
Yaw Ofori YeboahVolta Regional Health Directorate, Ghana Health Service, Ho, Ghana.
John Kofi OdoomNoguchi Memorial Institute for Medical Research, Legon, Accra, Ghana.
Senanu Kwesi DjokotoVolta Regional Health Directorate, Ghana Health Service, Ho, Ghana.
Ernest AkyerekoPublic Health Division, Ghana Health Service, Accra, Ghana.
Abdulaziz MamuduNkwanta North District Health Directorate, Ghana Health Service, Nkwanta, Ghana.
Mukaila DiwuraKrachi-Nchumuru District Health Directorate, Ghana Health Service, Krachi, Ghana.
William OpareExpanded Programme on Immnunization, Ghana Health Service, Accra, Ghana.
Patrick AvevorWorld Health Organization, Country Office, Accra, Ghana.
Stanley DiamenuWorld Health Organization, Country Office, Accra, Ghana.
Sally-Ann OheneWorld Health Organization, Country Office, Accra, Ghana.
Ernest KenuGhana Field Epidemiology and Laboratory Training Programme, University of Ghana School of Public Health, Accra, Legon, Ghana.
Franklin Asiedu-BekoePublic Health Division, Ghana Health Service, Accra, Ghana.
Ghana Health Service · GHUniversity of Ghana · GHNoguchi Memorial Institute for Medical Research · GH

Funding

World Health Organization 001
6 · The paper itself

Abstract

backgroundThe global switch from trivalent oral poliovirus vaccine (OPV) to bivalent OPV in April 2016 without corresponding co-administration of inactivated poliovirus vaccine (IPV) until June 2018, created a cohort of poliovirus type 2 naïve children with risk of developing vaccine-derived poliovirus type 2 (VDPV2). In November and December 2019, two cases of circulating vaccine-derived poliovirus type 2 (cVDPV2) were confirmed in quick succession through Acute Flaccid Paralysis (AFP) surveillance in two nomadic pastoralist settlements in Oti Region. We investigated to determine the outbreak extent, identify risk factors and implement control and preventive measures.

methodsWe interviewed case-patients' families, abstracted immunization records, assessed AFP surveillance and conducted rapid OPV and IPV vaccination coverage surveys. Using AFP case definition of any child less than 15 years in the community with sudden onset of paralysis from July to November 2019 (in case-patient 1's district) and August to December 2019 (in case-patient 2's district), we conducted active case search. Stool samples from apparently healthy children and close contacts of the case-patients were collected and tested for poliovirus. We conducted environmental assessment of the community to identify potential risk factors.

resultsCase-patient 1 was an eight-year-old female who had taken two doses of OPV while case-patient 2 was an eight-month-old male who had taken three out of required four OPV doses in addition to IPV at seven months. Families of both case-patients had either travelled to or received visitors from areas with confirmed cVDPV2. Of all children surveyed, eight (29.6%) of 27 and three (18.8%) of 16 eligible children in communities of case-patient 1 and 2 respectively had received required four doses of OPV. No AFP case was found in both communities and surrounding settlements. Both communities had no source of potable water and toilet facilities. A stool sample from a contact of case-patient 1 tested positive for cVDPV2.

conclusionOutbreaks of cVDPV2 occurred in insanitary, under-vaccinated nomadic pastoralist settlements in Oti Region. Three rounds of monovalent OPV vaccination campaigns for children under 5 years of age in the districts and region as well as countrywide IPV vaccination campaign for poliovirus type 2 naïve cohort were conducted.

Indexed as

CirculatingOutbreakPastoralistPoliovirusVaccinationVaccine-derived

Identifiers

PMID36600260
PMCPMC9811735
OpenAlexW4313546092

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.